Trial site
Taipei Municipal Wan Fang Hospital
Taipei, 116, TaiwanNot linked to an institution yet
The trials here
What the 12 trials at this site are about, from their registry records.
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Recruiting7 trials
- Active, not recruiting5 trials
- Lead sponsor
- Regeneron Pharmaceuticals6 trials
- PharmaEssentia2 trials
- National Taiwan University Hospital1 trial
- Pfizer1 trial
- Taipei Medical University1 trial
- and 1 more
Running trials
Recruiting
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT07222761· Phase 3· Regeneron Pharmaceuticals· Source
Contact: Clinical Trials Administrator
Active, not recruiting
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033· Phase 3· PharmaEssentia· Source
Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
NCT06787612· Phase 2· Regeneron Pharmaceuticals· Source
Contact: Clinical Trials Administrator
Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
NCT06292780· Phase 1/2· Regeneron Pharmaceuticals· Source
Contact: Clinical Trials Administrator
Active, not recruiting
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
NCT06161441· Phase 2· Regeneron Pharmaceuticals· Source
Recruiting
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
NCT06149286· Phase 3· Regeneron Pharmaceuticals· Source
Contact: Clinical Trials Administrator
Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
NCT06091254· Phase 3· Regeneron Pharmaceuticals· Source
Contact: Clinical Trials Administrator
Active, not recruiting
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
NCT05654623· Phase 3· Pfizer· Source
Recruiting
Proximal- Versus Distal-Prioritized Robotic Practice Plus Kinetic Exergaming in Stroke Rehabilitation
NCT05492175· Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation· Source
Contact: Keh-Chung Lin, ScD
Active, not recruiting
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
NCT04285086· Phase 3· PharmaEssentia· Source
Recruiting
Proximal Priority Versus Distal Priority Robotic Priming Effects in Patients With Chronic Stroke
NCT04446273· National Taiwan University Hospital· Source
Contact: Han-Ting Tsai, MS
Active, not recruiting
Enhancing Community Participation for Stroke Survivors With Cognitive Impairments
NCT03792061· Taipei Medical University· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error